AIG
VIRX

American International Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

American International Group’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,000
Closed -$86K – 3301
2022
Q1 		$86K Sell
18,000
-1,266
-7% -$3.81K ﹤0.01% 2649
2021
Q4 		$70K Sell
19,266
-576
-3% -$3.07K ﹤0.01% 2856
2021
Q3 		$159K Sell
19,842
-472
-2% -$4.65K ﹤0.01% 2567
2021
Q2 		$230 Buy
+20,314
New +$204K ﹤0.01% 2421
2015
Q3 		– Sell
-5
Closed -$3.01K – 5079
2015
Q2 		$3.01K Sell
5
-143
-97% -$76K ﹤0.01% 4840
2015
Q1 		$76.2K Sell
148
-308
-68% -$155K ﹤0.01% 3754
2014
Q4 		$244K Sell
456
-64
-12% -$28.8K ﹤0.01% 2776
2014
Q3 		$780K Buy
520
+14
+3% +$20.3K ﹤0.01% 1755
2014
Q2 		$692K Buy
506
+62
+14% +$71.9K ﹤0.01% 1891
2014
Q1 		$616K Sell
444
-4
-0.9% -$4.65K ﹤0.01% 1918
2013
Q4 		$446K Sell
448
-27
-6% -$27.9K ﹤0.01% 2116
2013
Q3 		$494K Buy
475
+1
+0.2% +$1.07K ﹤0.01% 1988
2013
Q2 		$516K Buy
+474
New +$528K ﹤0.01% 1834

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

American International Group's VIRX Position: Q2 2022 in Review

American International Group sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2022, closing a stake of 18,000 shares — an estimated $86K sold.

American International Group first reported a position in VIRX in Q2 2013 and held it in 13 quarters. The position peaked at $780K in Q3 2014. 63 funds tracked by Wall St. Rank hold VIRX as of Q2 2022.

  • American International Group reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 18,000 Viracta Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $86K.
  • American International Group first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • American International Group's Viracta Therapeutics, Inc. Common Stock position peaked at $780K in Q3 2014.
  • 63 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.